HTB

HTB: no. 8 (3 August 2022) PDF downloads

PDF files use a single column layout that makes it easy to read on tablets and other hand held devices.

HIV no 8 – August 2022 – 1 column (PDF)

This issue leads with first reports from the AIDS 2022 conference in Montreal.

It also includes significant reports on the current monkeypox crisis.

HTB no 7 – July 2022 – 1 column (PDF)

Expanded updates and concerns about monkeypox (MPX) in the UK – including the importance of emergency funding to provide adequate responses: for diagnosis, treatment, vaccines and other support.

Plus other news from CROI 2022, lenacapavir, bNAbs in adults and children, COVID variants BA.4 and BA.5 in the UK, monitoring PrEP and UK funding for UNAIDS.., .

HTB no 6 – June 2022 – 1 column (PDF)

New concerns about monkeypox virus (MPV) including statements from BHIVA and ECDC, with case reports from the UK.

Plus other news from CROI 2022 on the VESTED study, lenacapavir, plans for generic long-acting cabotegravir as PrEP and more.., .

Previous issues 2022

HTB no 5 – May 2022 – 1 column (PDF)

Appeals for Ukraine. Third reports from CROI 2022: NADIR and VISEND studies, COVID-19 research.

Plus other news on new paediatric formulation of dolutegravir-based ART, access to ibalizumab in the EU, COVID-19, opt-out HIV testing in A&E departments, .

HTB no 4 – April 2022 – 1 column (PDF)

Appeals for Ukraine. Second reports from CROI 2022: islatravir, diabetes, COVID-19, mental health, NATLD, PEP packs, cure and more.

Plus news on COVID-19 including fourth vaccine shots…

HTB 3: March 2022 – (1 March 2022)

Ukraine invaded – EACS statement.
First reports from CROI 2022: Biktarvy 5 years, lenacapravir naive and experienced. CAB/RPV-LA (ATLAS-2M), HIV remission and cure research, bNAbs, cabotegravir-LA PrEP.

Plus menopause and HIV, news on COVID-19 and more…

Plus news on COVID-19.

HTB 1/2 January/February 2022 – (7 February 2022)

ART news included UK guidelines to access CAB/RPL-LA injections, impact on preserving telomere length, integrase resistance in HIV-2 and more.

Plus news on COVID-19.

Links to other websites are current at date of posting but not maintained.